Article
Dasatinib boosts γδ T cell expansion and memory phenotypes with enhanced antitumor immunity.
Cancer immunology, immunotherapy : CII - 2 Mar 2026
Lin Jeng-Rong, Song Ying-Chyi, Chou Yu-Lun, Chen Yun-Jhen, Hsiao Chi, Li Ju-Pi, Ho Ying-Jui, Liao Wen-Chieh, Yen Hung-Rong, Liu Chiung-Hui
Abstract excerpt
Γδ T cells offer unique advantages in cancer immunotherapy because of their MHC-independent recognition of tumor antigens and innate cytotoxic potential. However, conventional ex vivo expansion protocols using zoledronic acid (Zol) and IL-2 often lead to terminal differentiation and diminished effector function. In this study, we performed a flow cytometry-based screen of an FDA-approved compound library to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
